vorinostat has been researched along with Acute Onset Vascular Dementia in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, N | 1 |
| Fang, YC | 1 |
| Lee, HY | 1 |
| Singh, A | 1 |
| Nepali, K | 1 |
| Lin, MH | 1 |
| Yeh, TK | 1 |
| Lai, MJ | 1 |
| Chan, L | 1 |
| Tu, YK | 1 |
| Banerjee, S | 1 |
| Hu, CJ | 1 |
| Liou, JP | 1 |
1 other study available for vorinostat and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment.
Topics: Animals; Azepines; Cell Line, Tumor; Clomipramine; Cognitive Dysfunction; Dementia, Vascular; Dose-R | 2020 |